Hangzhou Zhongtai Cryogenic Technology Balance Sheet Health
Financial Health criteria checks 6/6
Hangzhou Zhongtai Cryogenic Technology has a total shareholder equity of CN¥3.3B and total debt of CN¥306.9M, which brings its debt-to-equity ratio to 9.3%. Its total assets and total liabilities are CN¥4.8B and CN¥1.5B respectively. Hangzhou Zhongtai Cryogenic Technology's EBIT is CN¥294.3M making its interest coverage ratio -12.3. It has cash and short-term investments of CN¥1.1B.
Key information
9.3%
Debt to equity ratio
CN¥306.88m
Debt
Interest coverage ratio | -12.3x |
Cash | CN¥1.11b |
Equity | CN¥3.30b |
Total liabilities | CN¥1.48b |
Total assets | CN¥4.78b |
Recent financial health updates
Recent updates
We Think Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Can Stay On Top Of Its Debt
Dec 17Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Might Have The Makings Of A Multi-Bagger
Oct 18Hangzhou Zhongtai Cryogenic Technology's (SZSE:300435) Upcoming Dividend Will Be Larger Than Last Year's
May 21Solid Earnings May Not Tell The Whole Story For Hangzhou Zhongtai Cryogenic Technology (SZSE:300435)
May 01Here's Why We Think Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Might Deserve Your Attention Today
Feb 29Financial Position Analysis
Short Term Liabilities: 300435's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 300435's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥60.7M).
Debt to Equity History and Analysis
Debt Level: 300435 has more cash than its total debt.
Reducing Debt: 300435's debt to equity ratio has reduced from 24.7% to 9.3% over the past 5 years.
Debt Coverage: 300435's debt is well covered by operating cash flow (162.7%).
Interest Coverage: 300435 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 06:18 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hangzhou Zhongtai Cryogenic Technology Corporation is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yigong Tao | China Galaxy Securities Co., Ltd. |
Ji Li | Topsperity Securities |
Xue Guo | Topsperity Securities |